KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nektar Therapeutics (NKTR) Revenue: 2009-2024

Historic Revenue for Nektar Therapeutics (NKTR) over the last 16 years, with Dec 2024 value amounting to $98.4 million.

  • Nektar Therapeutics' Revenue fell 51.13% to $11.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $62.6 million, marking a year-over-year decrease of 32.79%. This contributed to the annual value of $98.4 million for FY2024, which is 9.22% up from last year.
  • According to the latest figures from FY2024, Nektar Therapeutics' Revenue is $98.4 million, which was up 9.22% from $90.1 million recorded in FY2023.
  • In the past 5 years, Nektar Therapeutics' Revenue registered a high of $152.9 million during FY2020, and its lowest value of $90.1 million during FY2023.
  • Over the past 3 years, Nektar Therapeutics' median Revenue value was $92.1 million (recorded in 2022), while the average stood at $93.5 million.
  • Its Revenue has fluctuated over the past 5 years, first spiked by 33.41% in 2020, then plummeted by 33.36% in 2021.
  • Yearly analysis of 5 years shows Nektar Therapeutics' Revenue stood at $152.9 million in 2020, then plummeted by 33.36% to $101.9 million in 2021, then dropped by 9.67% to $92.1 million in 2022, then dropped by 2.10% to $90.1 million in 2023, then rose by 9.22% to $98.4 million in 2024.